| Literature DB >> 25587068 |
Kirti Bhatt1, Qingqing Wei1, Navjotsingh Pabla1, Guie Dong1, Qing-Sheng Mi2, Mingyu Liang3, Changlin Mei4, Zheng Dong5.
Abstract
Ischemia-reperfusion injury contributes to tissue damage and organ failure in clinical settings, but the underlying mechanism remains elusive and effective therapies are still lacking. Here, we identified microRNA 687 (miR-687) as a key regulator and therapeutic target in renal ischemia-reperfusion injury. We show that miR-687 is markedly upregulated in the kidney during renal ischemia-reperfusion in mice and in cultured kidney cells during hypoxia. MiR-687 induction under these conditions was mediated by hypoxia-inducible factor-1 (HIF-1). Upon induction in vitro, miR-687 repressed the expression of phosphatase and tensin homolog (PTEN) and facilitated cell cycle progression and apoptosis. Blockade of miR-687 preserved PTEN expression and attenuated cell cycle activation and renal apoptosis, resulting in protection against kidney injury in mice. Collectively, these results unveil a novel HIF-1/miR-687/PTEN signaling pathway in ischemia-reperfusion injury that may be targeted for therapy.Entities:
Keywords: acute renal failure; cell death; hypoxia; ischemia-reperfusion; renal injury
Mesh:
Substances:
Year: 2015 PMID: 25587068 PMCID: PMC4483585 DOI: 10.1681/ASN.2014050463
Source DB: PubMed Journal: J Am Soc Nephrol ISSN: 1046-6673 Impact factor: 10.121